Optimal Anemia Treatment in End Stage Renal Disease (ERSD)

• Status: Unknown status
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Clinical study aimed at improving anemia management in End Stage Renal Disease Patient (ESRD) on maintenance Hemodialysis with evidence of Chronic Kidney disease Mineral Bone Disorder (CKD-MBD)

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Azienda Ospedaliera Sant'Anna
• Collaborator: Amgen
• Treatments: Calcium; Vitamin D

Criteria

INCLUSION CRITERIA.

• Men and women

• Age >18 years

• Maintenance dialysis via Artero-Venous fistula

• ESA use

• iPTH between 300-600 pg/ml

• Hb between 10.0-11.5

• Kt/V greater/equal than 1.2

• Signed informed consent prior to the initiation of the study

EXCLUSION CRITERIA: None.